MDAA yields 0.46% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, MDAA + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDAA + MRK for your $10,000?
MDAA aims to outperform a 60/40 global equity-bond benchmark through a dynamic allocation across global equities, fixed income, and currencies. Investments consist of large- and mid-cap stocks, bond futures, currency derivatives, and low-cost index ETFs. The fund may also hold ADRs, GDRs, IDRs, and foreign securities. The equity portfolio ranges from nearly 100% exposure during bullish markets to zero or net short positions in bearish conditions. The fixed income allocations shift according to interest rate trends, and cash holdings increase during downturns to reduce risk. Currency exposure is managed through futures and options, with gold sometimes used as a proxy. The strategy is based on a top-down macroeconomic approach that shifts assets in response to economic, sector, and earnings outlooks. The fund may also use leverage through futures to amplify tactical returns.
Full MDAA Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.